Patients Discontinuing Weight-Loss Medications Gain Back Pounds Four Times Faster Than Those on Conventional Diets
Fresh analysis reveals that individuals who stop using popular weight-loss injections like Mounjaro or Wegovy tend to recover lost weight at a significantly accelerated pace than those who stop traditional diet and exercise plans.
Research printed in a major health publication points out that while overweight people frequently drop a large proportion of their total mass while undergoing treatment, the mass is regained at an average rate of nearly a kilo each month once they quit.
"Users buying such drugs need to be informed of the danger of fast rebound weight gain when the therapy is stopped," warns lead investigator Dr. Susan Jebb.
Such speed of recovery suggests a reversion to original mass within about one and a half years.
Comparing Therapies
The research, which looked at 37 of studies involving over 9,000 of patients, contrasted the effects of these new drugs with conventional dieting.
The team emphasize that individuals who lose weight through diet and exercise typically experience a more gradual weight regain—around 0.1 kg a month—once they finish.
Explaining the Quick Rebound
Experts suggest the mechanism of the drugs is key to understanding the amplified regain.
The injections copy a body's own chemical called glucagon-like peptide-1, which controls feelings of fullness.
"Sustained high doses of the hormone concentrations far above than normal could lead to the body to generate a reduced amount of its own natural hormone, and may also diminish responsiveness to its actions," explained Dr. Adam Collins, a dietetics expert.
"Stopping of this GLP-1 'fix' means appetite is uncontrolled, making excessive eating a significant risk."
A Lifelong Issue?
Health authorities suggest the jabs for individuals with obesity-related medical conditions, alongside prescribed diet and exercise modifications.
Professionals contend that, considering the significant potential of relapse, the therapy is often ongoing.
This view is echoed by drug manufacturers, who note that the findings "emphasize the persistent nature of excess weight," comparing it to managing diseases like hypertension.
User Testimonies
Individuals who have come off the medication report a intense resurgence of hunger.
"It felt as if a switch flipping and you become extremely hungry," recalled a patient.
This challenge is compounded if users have not adopted lasting lifestyle or habit changes during therapy.
Widespread Adoption
Figures indicate that a significant number of adults in the UK have tried these injections in the last 12 months, with desire remaining high.
- Use is greater among females than males.
- The 40s and 50s age group shows the greatest level of interest.
- A large proportion obtain the medications through private prescriptions rather than public health services.
Finally, researchers caution that while these medications are potent agents for shedding pounds, they are not a standalone cure and long-term success hinges on ongoing lifestyle changes.
